-
Mashup Score: 1Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation - PubMed - 10 month(s) ago
BCMA-specific chimeric-antigen receptor (CAR) T cell therapy has led to high response rates and durable remissions in patients with relapsed refractory multiple myeloma. However, little data are available for patients after prior allogeneic stem cell transplantation (allo-SCT) in whom T cells are ch …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Cardiac Events After Standard of Care Idecabtagene Vicleucel for Relapsed and Refractory Multiple Myeloma - PubMed - 11 month(s) ago
Ide-cel CAR-T for RRMM is associated with similar cardiac events as other types of CAR-T. Worse baseline performance status and higher-grade CRS and neurotoxicity are associated with cardiac events post-BCMA-directed CAR-T-cell therapy. Our results suggest that the presence of cardiac events may con …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Cardiac Complications of CAR-T Therapy "Worse baseline PS and high grade CRS & neurotoxic are associated with cardiac events post Ide-cel" H/o Cardiac history not so much of an issue ! @MoffittNews Doris Hansen, Dae Lee https://t.co/WUy0mo2XPi
-
-
Mashup Score: 1
Code and models: https://github.com/mbzuai-oryx/XrayGPT
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
What's next in image recognition and #AIhealthcare? XrayGPT ! You can ask Xray and question you want and get input ? I am a proponent of #AIHealthcare, but this does make me a bit nervous! But in https://t.co/tH0p2S1bWK
-
-
Mashup Score: 1GPRC5D as a novel immunotherapeutic target in multiple myeloma - PubMed - 11 month(s) ago
GPRC5D as a novel immunotherapeutic target in multiple myeloma
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
GPRC5D - quickly evolving as an important target in #MM Nice, concise review by Dr Mailankody and team ! https://t.co/aFXm0eq6O2 https://t.co/DCeDDxxaZR
-
-
Mashup Score: 0
Chimeric antigen receptor (CAR)-reprogrammed T cell therapy is a novel and powerful treatment against hematological malignancies. Cytokine release syndrome (CRS) and other potentially life-threatening toxicities are known side effects which need appropriate management and supportive care. Coagulopat …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Coagulatopathy post CAR-T Cell therapy: A serious concern! Will we encounter similar issues with Bispecifics in MM? It's time to dive into clinical trials and real-world data. 49% of patients developed coagulation disorders, with 29% experience DIC ! https://t.co/nafkoboNhL
-
-
Mashup Score: 0Pre-clinical characterization of ISB 1342, a CD38xCD3 T-cell engager for relapsed/refractory multiple myeloma - 11 month(s) ago
Key Points. ISB 1342 exhibits potent killing of primary MM cells and MM cell lines with low sensitivity to daratumumab.ISB 1342 induced complete MM tumor eradic
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Bispecific antibody with a high-affinity Fab binding to CD38 on tumor cells on a different epitope than daratumumab and a detuned scFv domain affinity binding to CD3ε on T-cells tries to take this challenge on ! https://t.co/GZvGqWtbGb
-
-
Mashup Score: 1How technology will shape healthcare in 2023 - 11 month(s) ago
This year could represent an inflection point for real-world utilization of artificial intelligence, and standards could rise for health data privacy and cybersecurity, industry experts told Healthcare Dive.
Source: Healthcare DiveCategories: Hem/Oncs, Latest HeadlinesTweet-
COVID-19 turbocharged telehealth, making it widely accessible. Now, Healthcare is primed for a similar revolution with #ChatGPT in the world of AI/ML. The biggest use of AI will be in diagnostic tools and treatments. @RebeccaMPifer https://t.co/oIJW2abFYD
-
-
Mashup Score: 0
Artificial Intelligence (AI) has been rapidly transforming various aspects of our lives, and healthcare is no exception. The field of dentistry, too, is poised to benefit greatly from the integration of AI technologies. I believe one of the most promising uses of this technology is to automate chart review, a process that is currently manual and laborious. AI has already…
Source: www.linkedin.comCategories: Hem/Oncs, Latest HeadlinesTweet-
We all suffer from the nightmare of missing things in “chart review” ! Dentists are not agnostic to that issue..like missing a decaying tooth! Can AI help dentist improve how they provide dental care ? 🦷 poised to only improve as Dr Salirno describes: https://t.co/e4XiFkdxRI
-
-
Mashup Score: 0Ob-gyn residency programs take hit after Dobbs - 11 month(s) ago
Future physicians say they’re hesitant to train or work in abortion-restricted states.
Source: Healthcare BrewCategories: Hem/Oncs, Latest HeadlinesTweet-
In a struggling healthcare system, “Roe vs Wade” is having unsurmountable changes! In states with abortion laws, there is a sig decline in medical students applying for Ob-Gyn residency, an issue that can worsen and affect general maternal-fetal care. https://t.co/AuVl5lvQQz
-
-
Mashup Score: 0WHO calls for safe and ethical AI for health - 11 month(s) ago
The World Health Organization (WHO) is calling for caution to be exercised in using artificial intelligence (AI) generated large language model tools (LLMs) to protect and promote human well-being, human safety, and autonomy, and preserve public health.
Source: www.who.intCategories: Hem/Oncs, Latest HeadlinesTweet-
As Sam Altman said, “ Think of AI as atomic energy.” WHO proposes six principles to protect our patients 1. Protect Autonomy 2. Promote human well being 3. Ensure transparency 4. Foster accountability 5. Ensure inclusivity 6. Promote sustainability https://t.co/5utD9RYpjr
-
Small no's of pt but reassurance that prior-allogeneic stem cell transplant is NOT a contraindication for CAR-T cell therapy in #MMsM https://t.co/Vw1ccpvyg8